New Evidence-Based 3D Cell Culture Web Portal Launched by Reinnervate Ltd
News Oct 12, 2012
The new resource brings together a wide variety of information, protocols, peer-reviewed papers and videos to help not only those who are considering the adoption of 3D cell culture but also those already using this approach to growing cells in vitro.
‘We have created a central resource that will help scientist to learn why 3D cell culture may be beneficial, how they can evaluate 3D cell culture and how to pick the right type of Alvetex®Scaffold format for their experiments’ commented Barry Lynch, Marketing Manager at Reinnervate Ltd. ‘We are highlighting independent publications, testimonials from scientists already growing cells in 3D, validated protocols and videos showing how different 3D technologies stack up’, he added.
To support the launch of the new 3D cell culture resource, Reinnervate will run a series of webinars describing detailed scientific data comparing 3D and 2D cell culture experiments in the areas of;
Assessment of Cancer cell cytotoxicity in a novel 3D culture assay (9th Oct 2012)
Formation of Mesenchymal tissues in Alvetex®Scaffold derived from stem cells and other established cell lines (7th Nov 2012)
Modelling cancer cell invasion using novel technology for 3D cell culture (5th Dec 2012)
Full details can be found at http://www.reinnervate.com/campaign
New Class of Decoy Molecules that Prevent the Onset of PainNews
Researcher report a new method of reducing pain-associated behaviors with RNA-based medicine, creating a new class of decoy molecules that prevent the onset of pain.READ MORE
Fast-tracking T Cell Therapies with Immune-mimicking BiomaterialsNews
A new approach to amplify patient-specific T cells outside the body could increase the efficiency of cancer immunotherapies.READ MORE
New Class of Drugs for the Treatment of Advanced Lung DiseaseNews
Researchers have demonstrated the potential of a new class of drugs for the treatment of refractory chronic obstructive pulmonary disease, i.e. COPD.READ MORE